The landscape of modern medicine is shifting from broad-spectrum interventions to precise, ecological restorations. Faecal Microbiota Transplant (FMT) has emerged as a cornerstone of this movement, offering a transformative approach to treating dysbiosis-related conditions by harnessing the power of the human microbiome. As a premier Contract Research Organization (CRO), Creative Biolabs is dedicated to bridging the gap between innovative microbiome concepts and rigorous preclinical validation. Our end-to-end FMT research services empower pharmaceutical companies, biotechnology firms, and academic institutions to explore the therapeutic potential of the gut ecosystem with unmatched precision, quality, and scientific depth. Partner with us to unlock the next generation of microbial therapeutics through standardized, high-fidelity research solutions.
Overview of Faecal Microbiota Transplant (FMT)
FMT involves the transfer of a processed microbial community from a healthy donor into the gastrointestinal tract of a recipient. While historically associated with treating refractory Clostridioides difficile infections, FMT has evolved into a versatile research tool for investigating a wide array of systemic diseases.
In the preclinical context, FMT serves as the gold standard for establishing causality in microbiome-host interactions. By transplanting specific human or animal microbiotas into germ-free or antibiotic-depleted models, researchers can observe how microbial shifts influence metabolic, immunological, and neurological phenotypes. Our CRO provides the specialized infrastructure and expertise required to standardize this inherently variable process, ensuring that your preclinical data is reproducible, translatable, and high-impact.
Detailed Scope of Preclinical Services
We offer a modular and customizable suite of FMT services designed to meet the specific requirements of your experimental design. From donor screening to post-transplant efficacy analysis, our workflow is optimized for scientific rigor.
Formulation Services
Animal Models
Deliverables
Turnaround Time
Advanced Preparation and Formulation Services
Standardizing the delivery of microbiota is the greatest challenge in FMT research. We offer diverse formulation technologies to suit various animal models and delivery routes:
-
Freeze-Dried (Lyophilized) Capsule Preparation
We utilize proprietary cryoprotectant cocktails and low-temperature sublimation processes to create stable, highly concentrated microbial powders. These are encapsulated in enteric-coated shells designed to bypass the gastric acid of rodents or larger animal models, ensuring targeted release in the ileum or colon. This format is ideal for long-term dosing studies and stability testing.
-
Microbead (Encapsulation) Preparation
Using microfluidic or extrusion technologies, we embed live microbiota into biocompatible polymer matrices (such as alginate or chitosan). These microbeads provide superior protection against environmental stressors and allow for a sustained release profile within the intestinal lumen. Microbeads are particularly useful for dose-response studies and localized delivery research.
-
Intestinal Flora Suspension Preparation
For direct administration via oral gavage or rectal enema, we provide high-purity intestinal flora suspensions. Our process involves multi-stage filtration and gradient centrifugation to remove large particulate matter and dietary debris while retaining the full diversity of the microbial community. These suspensions are stabilized in oxygen-free, pH-buffered saline supplemented with pharmaceutical-grade cryoprotectants. This preparation is the "gold standard" for acute colonization studies and dose-escalation trials.
Animal Model Integration
We support FMT execution across various models:
-
Germ-Free (GF) Mouse Colonization: The cleanest way to study FMT, allowing for total control over the microbial environment without interference from indigenous flora.
-
Antibiotic-Depleted Models: Utilizing customized antibiotic cocktails to "clear the niche" before transplantation in SPF animals, mimicking clinical pre-treatment protocols.
-
Surgical and Non-Surgical Administration: Expert technicians perform oral gavage, rectal enema, or cecal injection to ensure precise delivery and minimal animal stress.
Deliverables
We pride ourselves on providing actionable data, not just raw material. Our standard deliverable package includes:
-
Characterization Report: High-resolution 16S rRNA or Shotgun Metagenomic sequencing of the FMT material before and after transplantation to track engraftment.
-
Viability Analysis: Quantitative PCR (qPCR) or flow cytometry data confirming the concentration of live bacteria in the final formulation.
-
Clinical Observations: Comprehensive logs of animal weight, stool consistency (Bristol scale equivalent), and behavioral markers throughout the study duration.
-
Histopathology and Biomarkers: Evaluation of intestinal morphology (H&E staining), cytokine profiles, and metabolite concentrations (GC-MS/LC-MS for SCFAs).
-
Final Study Report: A formal, audit-ready document summarizing the methodology, results, and statistical interpretations, suitable for regulatory submission or publication.
Turnaround Time
-
Standard Formulation (Suspension/Slurry): 4-6 weeks.
-
Advanced Formulation (Freeze-dried/Microbeads): 6-8 weeks.
-
Full Preclinical Efficacy Study: 3-6 months, depending on the disease model and duration of follow-up required.
Products for Preclinical Research
In addition to our services, we offer a catalog of standardized products for researchers who prefer to conduct their own experiments:
-
Standardized Fecal Reference Materials: Pre-characterized, frozen microbial slurries from validated healthy donors.
-
Pre-filled FMT Capsules for Rodents: Smaller capsules filled with standardized control or disease-state microbiota.
Our Technical Advantages
Choosing our CRO means accessing a platform built on precision and reliability:
Strict Anaerobic Workflow
Our entire processing chain, from collection to encapsulation, is conducted within anaerobic chambers. This preserves the most sensitive and therapeutically relevant anaerobic species that often die in standard laboratory settings.
High Microbial Diversity
Our optimized homogenization and filtration techniques maximize the recovery of the "dark matter" of the microbiome, ensuring the transplant is a true representation of the donor ecosystem.
Standardization and Reproducibility
We use automated encapsulation and freeze-drying equipment to minimize human error and batch-to-batch variation.
Integrated Multi-omics
We don't just perform the transplant; we provide the context. Our bioinformaticians integrate microbial data with host transcriptomics and metabolomics to provide a holistic view of the FMT's impact on the host.
Applications of FMT in Preclinical Research
The versatility of FMT allows it to be applied across nearly all therapeutic areas:
Researching Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), and Necrotizing Enterocolitis.
Investigating the role of the microbiome in Type 2 Diabetes, NAFLD/NASH, and obesity-driven systemic inflammation.
Studying how FMT can enhance the efficacy of Immune Checkpoint Inhibitors (ICIs) or mitigate the side effects of chemotherapy/radiation.
Exploring therapeutic transplants for Autism Spectrum Disorder (ASD), Alzheimer's, Parkinson's, and chronic stress models.
Assessing the impact of the microbiome on autoimmune conditions like Rheumatoid Arthritis or Multiple Sclerosis.
Necessity: Why Standardized FMT Services are Essential
Many researchers attempt "in-house" FMT, often leading to inconsistent results. The necessity for professional CRO involvement stems from:
-
Complexity of Oxygen Sensitivity: Many beneficial microbes are obligate anaerobes; even minutes of oxygen exposure can render the transplant ineffective.
-
Dose Precision: Without specialized encapsulation or calibrated suspensions, it is impossible to guarantee that a specific number of viable cells reaches the target site.
-
Regulatory Compliance: As the FDA and EMA move toward stricter guidelines for Live Biotherapeutic Products (LBPs), having preclinical data generated under standardized, CRO-quality conditions is vital for IND (Investigational New Drug) applications.
Target Customer Groups
Our services are specifically tailored for:
-
Biotech Startups: Looking for rapid proof-of-concept data.
-
Large Pharmaceutical Companies: Investigating microbiome-drug interactions.
-
Academic Labs: Requiring specialized anaerobic equipment or expertise.
-
Clinical Researchers: Seeking preclinical validation before moving into human trials.
Partner With Us Today
FMT is no longer an experimental curiosity; it is a foundational methodology for the next era of precision medicine. By shifting the focus from individual pathogens to entire microbial communities, FMT offers a holistic solution to the complexities of chronic disease. However, the path from discovery to therapy requires more than just biological insight-it requires technical mastery over one of the most volatile and complex biological materials known to science.
Creative Biolabs stands at the forefront of this field, providing the infrastructure, the standardized protocols, and the deep scientific expertise necessary to turn microbiome hypotheses into robust preclinical data. Whether you are exploring the metabolic signatures of the gut-brain axis or seeking to enhance the power of cancer immunotherapy, our FMT research platform provides the reliability and depth your project deserves. Our team of microbiologists, bioinformaticians, and animal model experts is ready to collaborate with you to design a study that meets the highest standards of scientific excellence.
Are you ready to elevate your microbiome research? Contact us today to schedule a technical consultation with one of our lead scientists. Let us help you transform the complexity of the gut ecosystem into your next therapeutic breakthrough.
Frequently Asked Questions (FAQs)
How do you ensure the safety of the donor material?
All donor material undergoes rigorous screening for a wide panel of pathogens, including multi-drug resistant organisms (MDROs), viruses (HIV, Hepatitis), and parasites.
Can you customize the bacterial concentration?
Yes. We can concentrate the microbiota to specific Colony Forming Units (CFU) per gram or per milliliter, ranging from 108 to 1011 CFU.
What is the shelf life of your freeze-dried products?
When stored at -80°C in our specialized buffers, our products maintain >90% viability for up to 12 months.
Do you support "Human-to-Mouse" transplants?
Absolutely. We assist in the ethical sourcing of human samples and the subsequent colonization of germ-free or antibiotic-treated mice.
